甘油三酯–葡萄糖指数与血浆致动脉硬化指数对心血管疾病的综合影响
Combined Effect of Triglyceride-Glucose Index and Atherogenic Index of Plasma on Cardiovascular Disease
DOI: 10.12677/acm.2025.1582194, PDF,   
作者: 曹柳柳：华北理工大学附属医院急诊科，河北 唐山；华北理工大学研究生学院，河北 唐山；武朝辉：山西医科大学研究生院，山西 太原；李 曼：暨南大学第一附属医院重症医学科，广东 广州；李佳澎, 孙丽霞*：华北理工大学附属医院急诊科，河北 唐山；吴寿岭：开滦总医院心血管内科，河北 唐山
关键词: 甘油三酯–葡萄糖指数；血浆致动脉粥样硬化指数；心血管疾病；缺血性心脏病；卒中；Triglyceride-Glucose Index； Atherogenic Index of Plasma； Cardiovascular Disease； Ischemic Heart Disease； Storke
摘要: 目的：探讨甘油三酯–葡萄糖指数(triglyceride-glucose index, TyG)与血浆致动脉硬化指数(atherogenic index of plasma, AIP)对新发心血管疾病(cardiovascular disease, CVD)的综合影响。方法：应用前瞻性队列研究，选取参加2006年度体检的开滦研究人群(n = 96,391)作为研究对象，将参与者按TyG和AIP中位数进行分组，分为低TyG &低AIP组，低TyG &高AIP组，高TyG &低AIP组，高TyG &高AIP组，每两年进行一次随访，以发生CVD (包括缺血性心脏病、卒中)、死亡或随访结束(2022年12月31日)为随访终点，分析TyG联合AIP与CVD发生风险的关联。结果：96,391名观察对象在平均随访14.17 ± 3.81年后，发生CVD者共11,378名。校正混杂因素后，与低TyG &低AIP组相比，高TyG &高AIP组发生CVD的HR (95%CI)为1.213 (1.156~1.272)，Ptrend < 0.05。结论：高TyG联合高AIP能促进CVD的发生。
Abstract: Objective: To investigate the combined effects of the triglyceride glucose index (TyG) and atherogenic index of plasma (AIP) on new-onset cardiovascular disease (CVD). Methods: This prospective cohort study used data from the Kailuan study population (n = 96,391), which included participants who underwent a physical examination in 2006. Based on median TyG and AIP values, participants were categorized into four groups: low TyG & low AIP, low TyG & high AIP, high TyG & low AIP, and high TyG & high AIP. Follow-up was conducted every two years. The study endpoints included incident CVD (ischemic heart disease or stroke), death, or the end of follow-up (December 31, 2022). The association between TyG combined with AIP and CVD risk was then analyzed. Results: After a mean follow-up period of 14.17 ± 3.81 years, 11,378 participants developed CVD. After multivariable adjustment, compared with the low TyG and low AIP group, the high TyG and high AIP group showed significantly increased CVD risk (HR = 1.213, 95%CI: 1.156~1.272); P for trend <0.05. Conclusion: High TyG combined with high AIP can promote the occurrence of CVD.
文章引用：曹柳柳, 武朝辉, 李曼, 李佳澎, 吴寿岭, 孙丽霞. 甘油三酯–葡萄糖指数与血浆致动脉硬化指数对心血管疾病的综合影响[J]. 临床医学进展, 2025, 15(8): 28-38. https://doi.org/10.12677/acm.2025.1582194

参考文献

[1] Martin, S.S., Aday, A.W., Almarzooq, Z.I., Anderson, C.A.M., Arora, P., Avery, C.L., et al. (2024) 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data from the American Heart Association. Circulation, 149, e347-e913. [Google Scholar] [CrossRef] [PubMed]
[2] Roth, G.A., Mensah, G.A., Johnson, C.O., et al. (2020) Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update from the GBD 2019 Study. Journal of the American College of Cardiology, 76, 2982-3021.
[3] Ferrari, A.J., Santomauro, D.F., Aali, A., et al. (2024) Global Incidence, Prevalence, Years Lived with Disability (YLDs), Disability-Adjusted Life-Years (DALYs), and Healthy Life Expectancy (HALE) for 371 Diseases and Injuries in 204 Countries and Territories and 811 Subnational Locations, 1990-2021: A Systematic Analysis for the Global Burden of Disease Study 2021. The Lancet, 403, 2133-2161.
[4] Simental-Mendía, L.E., Rodríguez-Morán, M. and Guerrero-Romero, F. (2008) The Product of Fasting Glucose and Triglycerides as Surrogate for Identifying Insulin Resistance in Apparently Healthy Subjects. Metabolic Syndrome and Related Disorders, 6, 299-304. [Google Scholar] [CrossRef] [PubMed]
[5] Tao, L., Xu, J., Wang, T., Hua, F. and Li, J. (2022) Triglyceride-Glucose Index as a Marker in Cardiovascular Diseases: Landscape and Limitations. Cardiovascular Diabetology, 21, Article No. 68. [Google Scholar] [CrossRef] [PubMed]
[6] Sánchez‐Íñigo, L., Navarro‐González, D., Fernández‐Montero, A., Pastrana‐Delgado, J. and Martínez, J.A. (2016) The Tyg Index May Predict the Development of Cardiovascular Events. European Journal of Clinical Investigation, 46, 189-197. [Google Scholar] [CrossRef] [PubMed]
[7] Liang, D., Liu, C. and Wang, Y. (2024) The Association between Triglyceride-Glucose Index and the Likelihood of Cardiovascular Disease in the U.S. Population of Older Adults Aged ≥ 60 Years: A Population-Based Study. Cardiovascular Diabetology, 23, Article No. 151. [Google Scholar] [CrossRef] [PubMed]
[8] Qin, Z., Zhou, K., Li, Y., Cheng, W., Wang, Z., Wang, J., et al. (2020) The Atherogenic Index of Plasma Plays an Important Role in Predicting the Prognosis of Type 2 Diabetic Subjects Undergoing Percutaneous Coronary Intervention: Results from an Observational Cohort Study in China. Cardiovascular Diabetology, 19, Article No. 23. [Google Scholar] [CrossRef] [PubMed]
[9] Zhao, M., Song, L., Sun, L., Wang, M., Wang, C., Yao, S., et al. (2021) Associations of Type 2 Diabetes Onset Age with Cardiovascular Disease and Mortality: The Kailuan Study. Diabetes Care, 44, 1426-1432. [Google Scholar] [CrossRef] [PubMed]
[10] Zhang, N., Wei, Z., Zhang, Y., Zhang, Q., Chen, Z., Tse, G., et al. (2023) Association of Life’s Essential 8 with Incident Atherosclerotic Cardiovascular Disease in Cancer Patients: The Kailuan Prospective Cohort Study. European Journal of Preventive Cardiology, 30, e78-e80. [Google Scholar] [CrossRef] [PubMed]
[11] 中国高血压防治指南修订委员会,高血压联盟(中国), 中国医疗保健国际交流促进会高血压病学分会, 等. 中国高血压防治指南(2024年修订版) [J]. 中华高血压杂志(中英文), 2024, 32(7): 603-700.
[12] 刘烨, 王海宁. 2021年ADA/EASD《糖尿病缓解专家共识》与《2022年ADA糖尿病指南: 2型糖尿病的预防和治疗中肥胖与体重管理》解读——糖尿病缓解的定义与治疗策略[J]. 临床内科杂志, 2022, 39(5): 299-302.
[13] 李建军. 《中国血脂管理指南(2023年)》核心要点解读[J]. 临床心血管病杂志, 2023, 39(7): 491-494.
[14] Levey, A.S., Stevens, L.A., Schmid, C.H., Zhang, Y., Castro, A.F., Feldman, H.I., et al. (2009) A New Equation to Estimate Glomerular Filtration Rate. Annals of Internal Medicine, 150, 604-612. [Google Scholar] [CrossRef] [PubMed]
[15] Stein, R., Ferrari, F. and Scolari, F. (2019) Genetics, Dyslipidemia, and Cardiovascular Disease: New Insights. Current Cardiology Reports, 21, Article No. 68. [Google Scholar] [CrossRef] [PubMed]
[16] Xiao, S., Wang, X., Zhang, G., Tong, M., Chen, J., Zhou, Y., et al. (2023) Association of Systemic Immune Inflammation Index with Estimated Pulse Wave Velocity, Atherogenic Index of Plasma, Triglyceride-Glucose Index, and Cardiovascular Disease: A Large Cross-Sectional Study. Mediators of Inflammation, 2023, Article ID: 1966680. [Google Scholar] [CrossRef] [PubMed]
[17] Zeng, Q., Zhong, Q., Zhao, L., An, Z. and Li, S. (2024) Combined Effect of Triglyceride-Glucose Index and Atherogenic Index of Plasma on Cardiovascular Disease: A National Cohort Study. Scientific Reports, 14, Article No. 31092. [Google Scholar] [CrossRef] [PubMed]
[18] Mancusi, C., de Simone, G., Best, L.G., Wang, W., Zhang, Y., Roman, M.J., et al. (2019) Myocardial Mechano-Energetic Efficiency and Insulin Resistance in Non-Diabetic Members of the Strong Heart Study Cohort. Cardiovascular Diabetology, 18, Article No. 56. [Google Scholar] [CrossRef] [PubMed]
[19] Selvi, N.M.K., Nandhini, S., Sakthivadivel, V., Lokesh, S., Srinivasan, A.R. and Sumathi, S. (2021) Association of Triglyceride-Glucose Index (TyG Index) with Hba1c and Insulin Resistance in Type 2 Diabetes Mellitus. Maedica—A Journal of Clinical Medicine, 16, 375-381. [Google Scholar] [CrossRef] [PubMed]
[20] Che, B., Zhong, C., Zhang, R., Pu, L., Zhao, T., Zhang, Y., et al. (2023) Triglyceride-glucose Index and Triglyceride to High-Density Lipoprotein Cholesterol Ratio as Potential Cardiovascular Disease Risk Factors: An Analysis of UK Biobank Data. Cardiovascular Diabetology, 22, Article No. 34. [Google Scholar] [CrossRef] [PubMed]
[21] Li, S., Guo, B., Chen, H., Shi, Z., Li, Y., Tian, Q., et al. (2019) The Role of the Triglyceride (Triacylglycerol) Glucose Index in the Development of Cardiovascular Events: A Retrospective Cohort Analysis. Scientific Reports, 9, Article No. 7320. [Google Scholar] [CrossRef] [PubMed]
[22] Barzegar, N., Tohidi, M., Hasheminia, M., Azizi, F. and Hadaegh, F. (2020) The Impact of Triglyceride-Glucose Index on Incident Cardiovascular Events during 16 Years of Follow-Up: Tehran Lipid and Glucose Study. Cardiovascular Diabetology, 19, Article No. 155. [Google Scholar] [CrossRef] [PubMed]
[23] Quiroga, B., Muñoz Ramos, P., Sánchez Horrillo, A., Ortiz, A., Valdivielso, J.M. and Carrero, J.J. (2022) Triglycerides-Glucose Index and the Risk of Cardiovascular Events in Persons with Non-Diabetic Chronic Kidney Disease. Clinical Kidney Journal, 15, 1705-1712. [Google Scholar] [CrossRef] [PubMed]
[24] Cui, H., Liu, Q., Wu, Y. and Cao, L. (2022) Cumulative Triglyceride-Glucose Index Is a Risk for CVD: A Prospective Cohort Study. Cardiovascular Diabetology, 21, Article No. 22. [Google Scholar] [CrossRef] [PubMed]
[25] Dobiásová, M. (2006) [AIP—Atherogenic Index of Plasma as a Significant Predictor of Cardiovascular Risk: From Research to Practice]. Vnitrni Lekarstvi, 52, 64-71.
[26] Quispe, R., Manalac, R.J., Faridi, K.F., Blaha, M.J., Toth, P.P., Kulkarni, K.R., et al. (2015) Relationship of the Triglyceride to High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio to the Remainder of the Lipid Profile: The Very Large Database of Lipids-4 (VLDL-4) Study. Atherosclerosis, 242, 243-250. [Google Scholar] [CrossRef] [PubMed]
[27] Dobiás̆ová, M. and Frohlich, J. (2001) The Plasma Parameter Log (TG/HDL-C) as an Atherogenic Index: Correlation with Lipoprotein Particle Size and Esterification Rate in apoB-Lipoprotein-Depleted Plasma (FERHDL). Clinical Biochemistry, 34, 583-588. [Google Scholar] [CrossRef] [PubMed]
[28] Anber, V., Griffin, B.A., McConnell, M., Packard, C.J. and Shepherd, J. (1996) Influence of Plasma Lipid and LDL-Subfraction Profile on the Interaction between Low Density Lipoprotein with Human Arterial Wall Proteoglycans. Atherosclerosis, 124, 261-271. [Google Scholar] [CrossRef] [PubMed]
[29] Won, K., Jang, M., Park, E.J., Park, H., Heo, R., Han, D., et al. (2020) Atherogenic Index of Plasma and the Risk of Advanced Subclinical Coronary Artery Disease Beyond Traditional Risk Factors: An Observational Cohort Study. Clinical Cardiology, 43, 1398-1404. [Google Scholar] [CrossRef] [PubMed]
[30] Si, Y., Fan, W., Han, C., Liu, J. and Sun, L. (2021) Atherogenic Index of Plasma, Triglyceride-Glucose Index and Monocyte-To-Lymphocyte Ratio for Predicting Subclinical Coronary Artery Disease. The American Journal of the Medical Sciences, 362, 285-290. [Google Scholar] [CrossRef] [PubMed]
[31] Boucher, J., Kleinridders, A. and Kahn, C.R. (2014) Insulin Receptor Signaling in Normal and Insulin-Resistant States. Cold Spring Harbor Perspectives in Biology, 6, a009191. [Google Scholar] [CrossRef] [PubMed]
[32] Elkanawati, R., Sumiwi, S. and Levita, J. (2024) Impact of Lipids on Insulin Resistance: Insights from Human and Animal Studies. Drug Design, Development and Therapy, 18, 3337-3360. [Google Scholar] [CrossRef] [PubMed]

为你推荐